Novartis has teamed up with Ratio Therapeutics in a $745m licensing and collaboration agreement to advance ...

On Monday, BridgeBio Pharma, Inc. (NASDAQ:BBIO) presented initial outcomes from the ATTRibute-CM open-label extension (OLE) ...

The fate is uncertain for a proposed high-profile ProKidney Corp. manufacturing plant in Greensboro after the Winston-Salem ...

all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter Clinuvel Pharmaceuticals is in advanced discussions with the ...

The upcoming Clinical Trials Supply and Outsourcing in Clinical Trials East Asia conferences will host discussions on supply ...

In this Science segment, we examine the European Medicines Agency's recent decision to recommend granting marketing ...

The EMA recommended that NUZ-001, formerly monepantel, be granted orphan medicinal product designation to treat ALS in Europe ...

Johnson & Johnson announced today more than 90 abstracts featuring data from the Company's differentiated blood cancer portfolio and pipeline will be presented at the 66th American Society of ...

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended AstraZeneca's Tagrisso ...

Q3 2024 Earnings Call Transcript November 18, 2024 Operator: Good afternoon, ladies and gentlemen, and welcome to the NRx ...

AstraZeneca’s Tagrisso (osimertinib) has been recommended for approval in the EU for treating adult patients with ...

The global consumption of antibiotics in Portugal increased by 2% between 2019-2023, double the average increase of 1% in ...